Mitigating Nonadherence Autumn 2016 Workshop

Co-Chairs: Thomas Shiovitz, MD / David McCann, PhD

Objective: To review findings of the working group and audience comments from the Spring 2016 ISCTM panel.

Work plan for the session:

1. To discuss whether a new working group on “Size vs Success in Phase 2/3 trials” should be created. 
2. To discuss how to get the recommendations of the Mitigating Nonadherence Working Group in front of stakeholders and implemented in front of future studies. 

Deliverable:

1. Elucidate three steps to implement working group recommendations
2. If a working group on Size vs Success is agreed upon, submit co-chairs and recommendations to the ISCTM scientific committee.